Myocardial bridge evaluation towards personalized medicine: study design and preliminary results of the RIALTO registry.

ABSTRACT: Myocardial bridge (MB) is the most frequent inborn coronary artery variant in which a portion of the myocardium overlies an epicardial coronary artery segment. Although MB has long been considered a benign entity, a growing body of evidence has suggested its association with angina and adverse cardiac events. However, to date, no data on long-term prognosis are available, nor on therapies improving cardiovascular outcomes. We are currently conducting an ambispective, observational, multicentre, study in which we enrol patients with a clinical indication to undergo coronary angiography (CA) and evidence of MB, aiming to describe the incidence of symptoms and cardiovascular events at baseline and at long-term follow-up (FUP). The role of invasive full-physiology assessment in modifying the d

SUBMITTER: D'Amario D 

PROVIDER: S-EPMC9650458 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature